Technical Analysis for STOK - Stoke Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 23.55 -0.59% -0.14
STOK closed down 0.59 percent on Friday, January 17, 2020, on 69 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical STOK trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Outside Day Range Expansion -0.59%
Oversold Stochastic Weakness -0.59%
Oversold Stochastic Weakness 0.13%
Down 3 Days in a Row Weakness 0.68%
Down 4 Days in a Row Weakness 0.68%
Oversold Stochastic Weakness 0.68%
Stochastic Reached Oversold Weakness -2.20%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Stoke Therapeutics is a biotechnology company that is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50 percent of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke was launched with investments by Apple Tree Partners. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.
Biotechnology Diseases Disease Proteins Genetic Diseases Epigenetics Severe Genetic Diseases

Is STOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 39.04
52 Week Low 19.21
Average Volume 126,957
200-Day Moving Average 0.00
50-Day Moving Average 25.65
20-Day Moving Average 25.89
10-Day Moving Average 24.41
Average True Range 1.68
ADX 11.21
+DI 16.87
-DI 21.60
Chandelier Exit (Long, 3 ATRs ) 24.89
Chandelier Exit (Short, 3 ATRs ) 28.11
Upper Bollinger Band 29.48
Lower Bollinger Band 22.31
Percent B (%b) 0.17
BandWidth 27.68
MACD Line -0.63
MACD Signal Line -0.29
MACD Histogram -0.3368
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.84
Resistance 3 (R3) 24.82 24.37 24.63
Resistance 2 (R2) 24.37 24.04 24.38 24.55
Resistance 1 (R1) 23.96 23.84 23.74 23.98 24.48
Pivot Point 23.51 23.51 23.40 23.52 23.51
Support 1 (S1) 23.10 23.18 22.88 23.12 22.62
Support 2 (S2) 22.65 22.98 22.66 22.55
Support 3 (S3) 22.24 22.65 22.48
Support 4 (S4) 22.26